Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2000

01-10-2000 | Meeting abstract

Quality management systems: the benefits of achieving ISO 9002

Authors: M Wheaton, S Munslow, MG Wallis

Published in: Breast Cancer Research | Special Issue 2/2000

Login to get access

Excerpt

Since taking part as a pilot in the NHSBSP 'Systematic Management of Quality for Breast Screening Services' exercise, we have obtained ISO 9002 certification. By taking this additional step we believe we have gained considerable benefits over a non-certificated quality management system. The seven principles of quality management are: (1) get organised; (2) have written procedures; (3) control key documents; (4) keep records; (5) carry out regular checks; (6) identify faults and correct them; and (7) communicate well. …
Metadata
Title
Quality management systems: the benefits of achieving ISO 9002
Authors
M Wheaton
S Munslow
MG Wallis
Publication date
01-10-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr258

Other articles of this Special Issue 2/2000

Breast Cancer Research 2/2000 Go to the issue

Meeting abstract

Does preoperative diagnosis reduce the number of operations required for treatment of screen-detected breast cancer?

Meeting abstract

Preoperative detection of multicentric breast cancer using tetrafosmin mammoscintigraphy

Meeting abstract

Minimally invasive treatment of the breast

Meeting abstract

Characterising breast tissue for the development of a tissue-equivalent phantom

Meeting abstract

Sclerosing lymphocytic lobulitis (SLL): a diagnostic challenge

Meeting abstract

Full-field digital mammography
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits